Daybreak Special: Ozempic isn't approved in India yet. We speak to someone who got it anyway

Daybreak

"I am willing to take the risk and give this drug a shot, for I've tried and tested almost all anti-obesity means myself—and even failed at some. As a first step, I am banking on other Ozempic users’ experience."

Meet Alifiya Khan, a health and education reporter at The Ken. Last month, she published a story on Ozempic, the 'miracle' weight-loss drug, and how easy it is to procure despite not being officially cleared for sale by the Indian government.

But this isn’t just another health story. Alifiya herself has been suffering from obesity for more than a decade now. For her procuring Ozempic wasn't just to further a story. She needed it for herself. After trying every fad diet, weight loss pill, and non-invasive procedure, to Alifiya, Ozempic is the light at the end of the tunnel.

In this episode, she joins hosts Snigdha and Rahel to share her story.

Tune in.

P.S. Not sure if you heard, but we hit 1 million downloads this month! We could not be more excited and grateful to you, our listeners. Could you do us a favour? Could you fill in this form and share your feedback? Also drop us a rating!

P.P.S. The Ken's podcast team is hiring! We are looking for a producer as well as a podcast host with at least 4-5 years of experience in the field. If you are interested or know someone who would be, please write to [e-mail] with 'Application for The Ken Podcasts' in the subject line.